Please enable JavaScript to continue using this application.

Compare $CELU vs $CRBU | Chartloom

Compare

$CELU vs $CRBU

Celularity Inc · Caribou Biosciences Inc

CELU

Celularity Inc

CRBU

Caribou Biosciences Inc

Compare $CELU vs $CRBU

Comparing Celularity Inc and Caribou Biosciences Inc

CELUCelularity Inc

CRBUCaribou Biosciences Inc

CELUCelularity Inc

Market cap

$45M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-51.0%

YTD performance

28.9%

52W performance

-27.4%

FCF yield

-29.3%

CRBUCaribou Biosciences Inc

Market cap

$46M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

10.0%

YTD performance

-71.1%

52W performance

-82.8%

FCF yield

-210.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CELU

CRBU

Detailed metrics comparison

CELU

Celularity Inc

CRBU

Caribou Biosciences Inc

Market Cap

CELU$45M

CRBU$46M

Enterprise Value

CELU$87M

CRBU$19M

Price

CELU$1.56

CRBU$0.46

P/E Ratio

CELUN/A

CRBUN/A

P/S Ratio

CELU1.70x

CRBU4.55x

EV/Sales

CELU3.27x

CRBU1.94x

EV/EBITDA

CELU0.00x

CRBU0.00x

P/B Ratio

CELU5.88x

CRBU1.33x

P/FCF Ratio

CELUN/A

CRBUN/A

EV/FCF

CELU-6.55x

CRBU-0.20x

PEG Ratio

CELUN/A

CRBUN/A

Forward P/E (NTM)

CELUN/A

CRBUN/A

Forward P/S (NTM)

CELUN/A

CRBUN/A

Revenue (TTM)

CELU$27M

CRBU$10M

Revenue Growth (YoY)

CELU-51.0%

CRBU10.0%

Forward Rev Growth

CELU0.0%

CRBU15.8%

Gross Margin (TTM)

CELU24.4%

CRBU0.0%

Operating Margin (TTM)

CELU0.0%

CRBU0.0%

EBITDA Margin (TTM)

CELU-203.4%

CRBU-1065.1%

Net Margin (TTM)

CELU-346.0%

CRBU-1030.4%

FCF Margin (TTM)

CELU-49.9%

CRBU-958.5%

Net Income (TTM)

CELU$-92M

CRBU$-103M

FCF (TTM)

CELU$-13M

CRBU$-96M

EPS (TTM)

CELU-$3.23

CRBU-$1.02

ROE (TTM)

CELU-27244.0%

CRBU-8911.0%

ROA (TTM)

CELU-7794.0%

CRBU-6247.0%

ROIC (TTM)

CELU-9204.0%

CRBU-8911.0%

Cash

CELU$6M

CRBU$26M

Debt

CELU$48M

CRBU$0

Net Cash/Debt

CELU$-42M

CRBU$26M

Current Ratio (TTM)

CELU0.15x

CRBU6.49x

Quick Ratio (TTM)

CELU0.14x

CRBU6.36x

Debt/Equity (TTM)

CELU4.79x

CRBU0.00x

Debt/Assets (TTM)

CELU0.0%

CRBU0.0%

Interest Coverage (TTM)

CELUN/A

CRBUN/A

Net Debt/EBITDA (TTM)

CELU0.00x

CRBU0.00x

Beta

CELU0.88

CRBU2.46

52W Performance

CELU-27.4%

CRBU-82.8%

YTD Performance

CELU28.9%

CRBU-71.1%

% from 52W High

CELU-38.8%

CRBU-87.0%

% from 52W Low

CELU178.5%

CRBU4.0%

Asset Turnover (TTM)

CELU0.23x

CRBU0.06x

FCF Yield (TTM)

CELU-29.3%

CRBU-210.7%

Earnings Yield (TTM)

CELU-203.4%

CRBU-226.5%

Dividend Yield (TTM)

CELUN/A

CRBUN/A

Rule of 40

CELU-101.0

CRBU-948.5

EV/GP/RG

CELUN/A

CRBUN/A

Ticker research

View CELU research View CRBU research

Metric	CELU Celularity Inc	CRBU Caribou Biosciences Inc
Market & Valuation
Market Cap	$45M	$46M
Enterprise Value	$87M	$19M
Price	$1.56	$0.46
P/E Ratio	N/A	N/A
P/S Ratio	1.70x	4.55x
EV/Sales	3.27x	1.94x
EV/EBITDA	0.00x	0.00x
P/B Ratio	5.88x	1.33x
P/FCF Ratio	N/A	N/A
EV/FCF	-6.55x	-0.20x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$27M	$10M
Revenue Growth (YoY)	-51.0%	10.0%
Forward Rev Growth	0.0%	15.8%
Profitability
Gross Margin (TTM)	24.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-203.4%	-1065.1%
Net Margin (TTM)	-346.0%	-1030.4%
FCF Margin (TTM)	-49.9%	-958.5%
Net Income (TTM)	$-92M	$-103M
FCF (TTM)	$-13M	$-96M
EPS (TTM)	-$3.23	-$1.02
ROE (TTM)	-27244.0%	-8911.0%
ROA (TTM)	-7794.0%	-6247.0%
ROIC (TTM)	-9204.0%	-8911.0%
Financial Health
Cash	$6M	$26M
Debt	$48M	$0
Net Cash/Debt	$-42M	$26M
Current Ratio (TTM)	0.15x	6.49x
Quick Ratio (TTM)	0.14x	6.36x
Debt/Equity (TTM)	4.79x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.88	2.46
52W Performance	-27.4%	-82.8%
YTD Performance	28.9%	-71.1%
% from 52W High	-38.8%	-87.0%
% from 52W Low	178.5%	4.0%
Efficiency & Yields
Asset Turnover (TTM)	0.23x	0.06x
FCF Yield (TTM)	-29.3%	-210.7%
Earnings Yield (TTM)	-203.4%	-226.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-101.0	-948.5
EV/GP/RG	N/A	N/A
Ticker research	View CELU research	View CRBU research

Valuation

P/S Ratio

CELU

1.70x

CRBU

4.55x

EV/FCF

CELU

-6.55x

CRBU

-0.20x

Growth & revenue

Revenue Growth TTM

CRBU

10.0%

CELU

-51.0%

Forward Revenue Growth

CRBU

15.8%

CELU

0.0%

Profitability & performance

Gross Margin

CELU

24.4%

CRBU

0.0%

ROE

CRBU

-8911.0%

CELU

-27244.0%

FCF Yield %

CELU

-29.3%

CRBU

-210.7%

52-Week Performance

CELU

-27.4%

CRBU

-82.8%

Detailed metrics comparison

CELU

Celularity Inc

CRBU

Caribou Biosciences Inc

Market Cap

CELU$45M

CRBU$46M

Enterprise Value

CELU$87M

CRBU$19M

Price

CELU$1.56

CRBU$0.46

P/E Ratio

CELUN/A

CRBUN/A

P/S Ratio

CELU1.70x

CRBU4.55x

EV/Sales

CELU3.27x

CRBU1.94x

EV/EBITDA

CELU0.00x

CRBU0.00x

P/B Ratio

CELU5.88x

CRBU1.33x

P/FCF Ratio

CELUN/A

CRBUN/A

EV/FCF

CELU-6.55x

CRBU-0.20x

PEG Ratio

CELUN/A

CRBUN/A

Forward P/E (NTM)

CELUN/A

CRBUN/A

Forward P/S (NTM)

CELUN/A

CRBUN/A

Revenue (TTM)

CELU$27M

CRBU$10M

Revenue Growth (YoY)

CELU-51.0%

CRBU10.0%

Forward Rev Growth

CELU0.0%

CRBU15.8%

Gross Margin (TTM)

CELU24.4%

CRBU0.0%

Operating Margin (TTM)

CELU0.0%

CRBU0.0%

EBITDA Margin (TTM)

CELU-203.4%

CRBU-1065.1%

Net Margin (TTM)

CELU-346.0%

CRBU-1030.4%

FCF Margin (TTM)

CELU-49.9%

CRBU-958.5%

Net Income (TTM)

CELU$-92M

CRBU$-103M

FCF (TTM)

CELU$-13M

CRBU$-96M

EPS (TTM)

CELU-$3.23

CRBU-$1.02

ROE (TTM)

CELU-27244.0%

CRBU-8911.0%

ROA (TTM)

CELU-7794.0%

CRBU-6247.0%

ROIC (TTM)

CELU-9204.0%

CRBU-8911.0%

Cash

CELU$6M

CRBU$26M

Debt

CELU$48M

CRBU$0

Net Cash/Debt

CELU$-42M

CRBU$26M

Current Ratio (TTM)

CELU0.15x

CRBU6.49x

Quick Ratio (TTM)

CELU0.14x

CRBU6.36x

Debt/Equity (TTM)

CELU4.79x

CRBU0.00x

Debt/Assets (TTM)

CELU0.0%

CRBU0.0%

Interest Coverage (TTM)

CELUN/A

CRBUN/A

Net Debt/EBITDA (TTM)

CELU0.00x

CRBU0.00x

Beta

CELU0.88

CRBU2.46

52W Performance

CELU-27.4%

CRBU-82.8%

YTD Performance

CELU28.9%

CRBU-71.1%

% from 52W High

CELU-38.8%

CRBU-87.0%

% from 52W Low

CELU178.5%

CRBU4.0%

Asset Turnover (TTM)

CELU0.23x

CRBU0.06x

FCF Yield (TTM)

CELU-29.3%

CRBU-210.7%

Earnings Yield (TTM)

CELU-203.4%

CRBU-226.5%

Dividend Yield (TTM)

CELUN/A

CRBUN/A

Rule of 40

CELU-101.0

CRBU-948.5

EV/GP/RG

CELUN/A

CRBUN/A

Ticker research

View CELU research View CRBU research

Metric	CELU Celularity Inc	CRBU Caribou Biosciences Inc
Market & Valuation
Market Cap	$45M	$46M
Enterprise Value	$87M	$19M
Price	$1.56	$0.46
P/E Ratio	N/A	N/A
P/S Ratio	1.70x	4.55x
EV/Sales	3.27x	1.94x
EV/EBITDA	0.00x	0.00x
P/B Ratio	5.88x	1.33x
P/FCF Ratio	N/A	N/A
EV/FCF	-6.55x	-0.20x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$27M	$10M
Revenue Growth (YoY)	-51.0%	10.0%
Forward Rev Growth	0.0%	15.8%
Profitability
Gross Margin (TTM)	24.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-203.4%	-1065.1%
Net Margin (TTM)	-346.0%	-1030.4%
FCF Margin (TTM)	-49.9%	-958.5%
Net Income (TTM)	$-92M	$-103M
FCF (TTM)	$-13M	$-96M
EPS (TTM)	-$3.23	-$1.02
ROE (TTM)	-27244.0%	-8911.0%
ROA (TTM)	-7794.0%	-6247.0%
ROIC (TTM)	-9204.0%	-8911.0%
Financial Health
Cash	$6M	$26M
Debt	$48M	$0
Net Cash/Debt	$-42M	$26M
Current Ratio (TTM)	0.15x	6.49x
Quick Ratio (TTM)	0.14x	6.36x
Debt/Equity (TTM)	4.79x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.88	2.46
52W Performance	-27.4%	-82.8%
YTD Performance	28.9%	-71.1%
% from 52W High	-38.8%	-87.0%
% from 52W Low	178.5%	4.0%
Efficiency & Yields
Asset Turnover (TTM)	0.23x	0.06x
FCF Yield (TTM)	-29.3%	-210.7%
Earnings Yield (TTM)	-203.4%	-226.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-101.0	-948.5
EV/GP/RG	N/A	N/A
Ticker research	View CELU research	View CRBU research